These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 16557221)
1. Mapping of myeloperoxidase epitopes recognized by MPO-ANCA using human-mouse MPO chimers. Erdbrügger U; Hellmark T; Bunch DO; Alcorta DA; Jennette JC; Falk RJ; Nachman PH Kidney Int; 2006 May; 69(10):1799-805. PubMed ID: 16557221 [TBL] [Abstract][Full Text] [Related]
2. Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves' disease treated with propylthiouracil. Fujieda M; Suzuki K; Sato H; Hattori M; Wada N; Tsuchiya M; Okamoto N; Murata T; Matsudaira M; Shimizu M; Ohta K; Naruse K; Sugihara S; Wakiguchi H Clin Nephrol; 2005 Jun; 63(6):437-45. PubMed ID: 15960145 [TBL] [Abstract][Full Text] [Related]
3. Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population. Suzuki K; Kobayashi S; Yamazaki K; Gondo M; Tomizawa K; Arimura Y; Nakabayashi K; Ozaki S; Yoshida M; Yoshida T; Tsusaka N; Muso E; Okazaki T; Hashimoto H Microbiol Immunol; 2007; 51(12):1215-20. PubMed ID: 18094540 [TBL] [Abstract][Full Text] [Related]
7. A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants. Tomizawa K; Mine E; Fujii A; Ohashi YY; Yamagoe S; Hashimoto Y; Ishida-Okawara A; Ito M; Tanokura M; Yamamoto T; Arimura Y; Nagasawa T; Mizuno S; Suzuki K J Clin Immunol; 1998 Mar; 18(2):142-52. PubMed ID: 9533658 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies. Schreiber A; Xiao H; Falk RJ; Jennette JC J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314 [TBL] [Abstract][Full Text] [Related]
9. Trafficking of QD-conjugated MPO-ANCA in murine systemic vasculitis and glomerulonephritis model mice. Hoshino A; Nagao T; Ito-Ihara T; Ishida-Okawara A; Uno K; Muso E; Nagi-Miura N; Ohno N; Tokunaka K; Naoe S; Hashimoto H; Yasuhara M; Yamamoto K; Suzuki K Microbiol Immunol; 2007; 51(5):551-66. PubMed ID: 17579266 [TBL] [Abstract][Full Text] [Related]
10. Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis. Gou SJ; Xu PC; Chen M; Zhao MH PLoS One; 2013; 8(4):e60530. PubMed ID: 23577119 [TBL] [Abstract][Full Text] [Related]
11. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976 [TBL] [Abstract][Full Text] [Related]
12. Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Wang C; Gou SJ; Xu PC; Zhao MH; Chen M Arthritis Res Ther; 2013; 15(6):R196. PubMed ID: 24252385 [TBL] [Abstract][Full Text] [Related]
14. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis. Xin G; Zhao MH; Wang HY Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182 [TBL] [Abstract][Full Text] [Related]
15. Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule. Ye H; Zhao MH; Gao Y; Guo XH; Wang HY Clin Exp Immunol; 2004 Oct; 138(1):179-82. PubMed ID: 15373922 [TBL] [Abstract][Full Text] [Related]
16. Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis. Yoshida M; Sasaki M; Nakabayashi I; Akashi M; Tomiyasu T; Yoshikawa N; Kojima T; Ohno N; Yamada M Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S28-32. PubMed ID: 19646343 [TBL] [Abstract][Full Text] [Related]
17. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis. Hilhorst M; Maria AT; Kavian N; Batteux F; Borderie D; Le Quellec A; van Paassen P; Guilpain P Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1769-F1776. PubMed ID: 30207165 [TBL] [Abstract][Full Text] [Related]
18. A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions. Locke IC; Leaker B; Cambridge G Clin Exp Immunol; 1999 Feb; 115(2):369-76. PubMed ID: 9933467 [TBL] [Abstract][Full Text] [Related]
19. The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis. Ooi JD; Chang J; Hickey MJ; Borza DB; Fugger L; Holdsworth SR; Kitching AR Proc Natl Acad Sci U S A; 2012 Sep; 109(39):E2615-24. PubMed ID: 22955884 [TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report. Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]